Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (211-220 of 355) with videos related to

Pageof 36
Sort By:
Cancer|May 28, 2009
Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancerSarah F Adams, Douglas A Levine, Mark G Cadungog, et al.
Journal of Translational Medicine|June 24, 2009
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancerHeather L Pulaski, Gregory Spahlinger, Ines A Silva, et al.
Molecular Therapy Oncolytics|February 6, 2020
miR-155 Overexpression in OT-1 CD8<sup>+</sup> T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor AntigenGwennaëlle C Monnot, Amaia Martinez-Usatorre, Evripidis Lanitis, et al.
Clinical and Translational Radiation Oncology|February 3, 2021
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumabWambaka Ange Mampuya, Hasna Bouchaab, Niklaus Schaefer, et al.
Nature Biotechnology|October 16, 2019
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomesJulien Racle, Justine Michaux, Georg Alexander Rockinger, et al.
Nature|July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cellsAndrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 27, 2022
Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsUte F Röhrig, Somi Reddy Majjigapu, Pierre Vogel, et al.
Analytical Chemistry|May 29, 2020
Multielemental Analysis of Low-Volume Samples Reveals Cancer-Specific Profile in Serum and Sorted Immune CellsTobias Konz, Caroline Monnard, Marcela Rincon Restrepo, et al.
Frontiers in Immunology|May 17, 2021
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population DiscoveryPetra Baumgaertner, Martial Sankar, Fernanda Herrera, et al.
Journal of Medicinal Chemistry|February 9, 2021
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) InhibitorsUte F Röhrig, Somi Reddy Majjigapu, Aline Reynaud, et al.
Pageof 36

Showing results (211-220 of 355) with videos related to

Sort By:
Pageof 36
Cancer|May 28, 2009
Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancerSarah F Adams, Douglas A Levine, Mark G Cadungog, et al.
Journal of Translational Medicine|June 24, 2009
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancerHeather L Pulaski, Gregory Spahlinger, Ines A Silva, et al.
Molecular Therapy Oncolytics|February 6, 2020
miR-155 Overexpression in OT-1 CD8<sup>+</sup> T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor AntigenGwennaëlle C Monnot, Amaia Martinez-Usatorre, Evripidis Lanitis, et al.
Clinical and Translational Radiation Oncology|February 3, 2021
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumabWambaka Ange Mampuya, Hasna Bouchaab, Niklaus Schaefer, et al.
Nature Biotechnology|October 16, 2019
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomesJulien Racle, Justine Michaux, Georg Alexander Rockinger, et al.
Nature|July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cellsAndrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 27, 2022
Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsUte F Röhrig, Somi Reddy Majjigapu, Pierre Vogel, et al.
Analytical Chemistry|May 29, 2020
Multielemental Analysis of Low-Volume Samples Reveals Cancer-Specific Profile in Serum and Sorted Immune CellsTobias Konz, Caroline Monnard, Marcela Rincon Restrepo, et al.
Frontiers in Immunology|May 17, 2021
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population DiscoveryPetra Baumgaertner, Martial Sankar, Fernanda Herrera, et al.
Journal of Medicinal Chemistry|February 9, 2021
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) InhibitorsUte F Röhrig, Somi Reddy Majjigapu, Aline Reynaud, et al.
Pageof 36